Tag: CORO
Persistent Organ Damage Common One Year After COVID-19
59 percent of individuals had organ impairment at one year; breathlessness, cognitive dysfunction, poor HRQoL also common
Transplant of Organs From SARS-CoV-2-Positive Donors Safe
Outcomes for hospital length of stay, 30-day mortality, 30-day graft loss similar for nucleic acid test-positive and -negative donors
FDA Approves First Home Test to Detect Both Flu and COVID-19
Test will be sold without a prescription and can be used by anyone 14 years and older or by an adult on children ages 2 years and older
Incident CVD, Mortality Risk Heightened for at Least One Year After COVID-19
Short- and long-term risks found in large study of patients with COVID-19 versus matched contemporary and historical cohorts
Parents Weigh Complex Factors in COVID-19 Vaccination Decisions
Parents report a mix of factors, including scientific evidence and political and social pressures, influencing their decision
Symptom and Viral RNA Rebound Common After Mild, Moderate COVID-19
Rebound is common in untreated outpatients, but combination of symptom and viral rebound occurs rarely
Natural Protection Against Reinfection With BA.1 COVID-19 Variant Lower
However, protection against severe disease remains high at 88.9 percent for omicron BA.1 at 40 weeks
Long COVID Tied to Lower Likelihood of Employment
Participants reporting any cognitive symptoms had lower likelihood of working full time
Moderna Will Offer Free COVID-19 Shots to Uninsured After PHE Ends
The U.S. public health emergency declaration is scheduled to end in May
Long COVID Seen in Most Cancer Patients After Infection
Other than female sex, no factors predict development of long-lasting symptoms
